Epidemiology & Risk Factors

  • Pathogens: Opportunistic fungi of order Mucorales (Rhizopus, Mucor, Lichtheimia).
  • Primary Risk Factor: Uncontrolled DM with DKA (high glucose and acidic environment allow fungal proliferation via ketone reductase).
  • Other Risk Factors:
    • Iron overload or Deferoxamine therapy (fungus uses iron as growth factor).
    • Hematologic malignancies (e.g., AML), prolonged neutropenia.
    • Solid organ or hematopoietic stem cell transplant.
    • High-dose chronic systemic corticosteroid use.

Clinical Features

  • Rhinocerebral Mucormycosis (classic presentation in DKA):
    • Rapidly progressive facial pain, headache, fever, purulent nasal discharge.
    • Black necrotic eschar on nasal turbinates, septum, or hard palate (pathognomonic, secondary to tissue ischemia/angioinvasion).
    • Periorbital swelling, proptosis, ophthalmoplegia, loss of vision (orbital apex syndrome).
    • Cranial nerve deficits (CN III, IV, VI, V1, V2).
    • Altered mental status, lethargy (CNS extension).
  • Pulmonary Mucormycosis (common in severe neutropenia):
    • Fever, cough, hemoptysis, pleuritic chest pain.
  • Cutaneous Mucormycosis:
    • Necrotic skin lesions in trauma or burn patients.

Diagnosis

  • Initial: High clinical suspicion in at-risk patient (DKA + facial pain/black eschar) →\rightarrow→ direct visualization via nasal endoscopy.
  • Imaging: CT or MRI of sinuses/brain (shows sinus opacification, bone destruction, retro-orbital extension, or carotid artery thrombosis).
  • Confirmatory/Gold Standard: Tissue biopsy with histopathology.
    • Histopathology: Broad, non-septate (or sparingly septate) hyphae branching at right angles (90°).
    • Hallmark Feature: Angioinvasion leading to vascular thrombosis and tissue necrosis.
    • Fungal culture (confirmative, but treatment must not be delayed for results).

Differential Diagnostics

  • Invasive Aspergillosis:
    • Differentiated by narrow, septate hyphae branching at acute angles (45°).
    • More common in prolonged neutropenia/transplant; rare in DKA.
  • Bacterial Orbital Cellulitis / Sinusitis:
    • Absence of black necrotic eschar; no response to broad-spectrum Abx.
  • Cavernous Sinus Thrombosis (Bacterial):
    • Similar CN involvement, but lacks necrotic mucosal lesions and fungal hyphae on biopsy.

Management

  1. Immediate Surgical Debridement:
    • Surgical emergency; radical debridement of all necrotic tissue is essential for survival.
  2. First-Line Antifungal:
    • High-dose IV Liposomal Amphotericin B (start immediately upon clinical suspicion before biopsy confirmation).
  3. Correction of Underlying Etiology:
    • Aggressive management of DKA (IV insulin, fluids).
    • Discontinue iron chelators (deferoxamine).
    • Taper immunosuppressive therapy/steroids if feasible.
  4. Step-Down / Maintenance Therapy:
    • Oral Isavuconazole or Posaconazole after initial clinical response to amphotericin B.